Xue Wu

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Lymph Node Metastasis

Combination Therapy

Dna Damage Response

Top Venues

The Journal of experimental medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Dianxing Hu, Ensong Guo, Bin Yang, Xu Qin, Yu Fu, Junpeng Fan, Xucui Zhuang, Qianqian Yao, Funian Lu, Wenting Li, Rourou Xiao, Xue Wu, Xiaohang Yang, Zizhuo Wang, Chen Liu, Lixin You, Rongyu Zang, Qi Zhou, Weidong Zhao, Gang Chen, Chaoyang Sun
Mutation profiles in circulating cell-free DNA predict acquired resistance to olaparib in high-grade serous ovarian carcinoma. Cancer science 113 (8) (2022)
Xue Wu, Xiaoyan Kang, Xiaoxiao Zhang, Wan Xie, Yue Su, Xiaoyu Liu, Lili Guo, Ensong Guo, Fuxia Li, Dianxing Hu, Xu Qin, Yu Fu, Wenju Peng, Jiedong Jia, Changyu Wang
WEE1 inhibitor and ataxia telangiectasia and RAD3-related inhibitor trigger stimulator of interferon gene-dependent immune response and enhance tumor treatment efficacy through programmed death-ligand 1 blockade. Cancer science 112 (11) (2021)
Ensong Guo, Rourou Xiao, Yifan Wu, Funian Lu, Chen Liu, Bin Yang, Xi Li, Yu Fu, Zizhuo Wang, Yuan Li, Yuhan Huang, Fuxia Li, Xue Wu, Lixin You, Tianyu Qin, Yiling Lu, Xiao-Yuan Huang, Ding Ma, Gordon B Mills, Chaoyang Sun, Gang Chen
WEE1 inhibition induces anti-tumor immunity by activating ERV and the dsRNA pathway. The Journal of experimental medicine 219 (1) (2021)